Cargando…

End-tidal carbon dioxide monitoring may be associated with a higher possibility of return of spontaneous circulation during out-of-hospital cardiac arrest: a population-based study

BACKGROUND: During cardiac arrest, end-tidal carbon dioxide (ETCO(2)) monitoring is recommended as a chest compression performance indicator. However, its frequency of use during out-of-hospital cardiac arrest (OHCA) and its benefits have never been evaluated in real clinical situations. OBJECTIVE:...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jiun-Jia, Lee, Yi-Kung, Hou, Sheng-Wen, Huang, Ming-Yuan, Hsu, Chen-Yang, Su, Yung-Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4657353/
https://www.ncbi.nlm.nih.gov/pubmed/26597847
http://dx.doi.org/10.1186/s13049-015-0187-y
Descripción
Sumario:BACKGROUND: During cardiac arrest, end-tidal carbon dioxide (ETCO(2)) monitoring is recommended as a chest compression performance indicator. However, its frequency of use during out-of-hospital cardiac arrest (OHCA) and its benefits have never been evaluated in real clinical situations. OBJECTIVE: We investigated OHCA patients in Taiwan to evaluate the frequency of ETCO(2) monitoring and its effects on sustained return of spontaneous circulation (ROSC). METHODS: We sampled the Taiwan National Health Insurance claims database, which contains 1 million beneficiaries. All adult beneficiaries older than 18 years who presented with OHCA and received chest compression between 1 January 2005 and 31 December 2012 were enrolled. We further identified patients with ETCO(2) monitoring and matched each 1 with 20 patients who did not receive ETCO(2) monitoring based on their propensity scores. A simple conditional logistic regression model was applied to compare the odds ratio (OR) for sustained ROSC in the matched cohorts. RESULTS: A total of 5041 OHCA patients were enrolled. The frequency of ETCO(2) monitoring has increased since 2010 but still is low. After matching, 53 patients with ETCO(2) monitoring and 1060 without ETCO(2) monitoring were selected. The OR of sustained ROSC in the ETCO(2) group was significantly increased (2.38, 95 % CI 1.28–4.42). CONCLUSION: Patients who received ETCO(2) monitoring during OHCA had a higher possibility of sustained ROSC, but the overall use of ETCO(2) monitoring is still low despite strong recommendations for its use. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13049-015-0187-y) contains supplementary material, which is available to authorized users.